Aktuellt
SENASTE
Redeye is impressed by the partnership with Medtronic in the US for IRRAflow and argues that it significantly validates the product’s value proposition. We anticipate a significant share price reaction of c30% on the back of this potentially case-altering news.
LÄS MER
